Samlyn Capital’s Dermira, Inc. DERM Stock Holding History

Samlyn Capital’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-146,000	Closed	-$4.98M	–	164
2017 Q1	$4.98M	Buy	146,000 +19,000	+15%	+$613K	0.12%	119
2016 Q4	$3.85M	Buy	+127,000	New	+$4.09M	0.09%	113

Other funds holding DERM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samlyn Capital's DERM Position: Q2 2017 in Review

Samlyn Capital sold out of Dermira, Inc. (DERM) in Q2 2017, closing a stake of 146,000 shares — an estimated $4.98M sold.

Samlyn Capital first reported a position in DERM in Q4 2016 and held it in 2 quarters. The position peaked at $4.98M in Q1 2017. 121 funds tracked by Wall St. Rank hold DERM as of Q2 2017.

Samlyn Capital reported no remaining Dermira, Inc. position as of Q2 2017 after selling out during the quarter.
Samlyn Capital sold 146,000 Dermira, Inc. shares in Q2 2017, an estimated $4.98M.
Samlyn Capital first reported a position in Dermira, Inc. in Q4 2016 and held it in 2 quarters.
Samlyn Capital's Dermira, Inc. position peaked at $4.98M in Q1 2017.
121 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2017.

Based on Samlyn Capital's 13F filing for Q2 2017, filed 14 Aug 2017.